Elevation Oncology (NASDAQ:ELEV) Coverage Initiated at Piper Sandler
Piper Sandler initiated coverage on shares of Elevation Oncology (NASDAQ:ELEV – Free Report) in a report issued on Friday morning, MarketBeat reports. The firm issued an overweight rating and a $10.00 target price on the stock. A number of other research firms also recently weighed in on ELEV. JMP Securities reaffirmed a market outperform rating […]
More Stories
Cantor Fitzgerald Reiterates Overweight Rating for Uber Technologies (NYSE:UBER)
Uber Technologies (NYSE:UBER – Get Free Report)‘s stock had its “overweight” rating reaffirmed by equities research analysts at Cantor Fitzgerald...
Berkshire Hathaway Inc Sells 5,192,207 Shares of Bank of America Co. (NYSE:BAC) Stock
Bank of America Co. (NYSE:BAC) major shareholder Berkshire Hathaway Inc sold 5,192,207 shares of the company’s stock in a transaction...
Anthony Rozic Sells 155,000 Shares of Goodman Group (ASX:GMG) Stock
Goodman Group (ASX:GMG – Get Free Report) insider Anthony Rozic sold 155,000 shares of the business’s stock in a transaction...
Coastal Financial Co. (NASDAQ:CCB) CEO Eric M. Sprink Sells 6,000 Shares
Coastal Financial Co. (NASDAQ:CCB – Get Free Report) CEO Eric M. Sprink sold 6,000 shares of the firm’s stock in...
J. Alberto Arias Sells 85,167 Shares of Sierra Metals Inc. (TSE:SMT) Stock
Sierra Metals Inc. (TSE:SMT – Get Free Report) Director J. Alberto Arias sold 85,167 shares of the company’s stock in...
JPMorgan Chase & Co. Increases Capital One Financial (NYSE:COF) Price Target to $157.00
Capital One Financial (NYSE:COF) had its price objective lifted by equities researchers at JPMorgan Chase & Co. from $156.00 to...